Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation

<p>Abstract</p> <p>Background</p> <p>Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are often linked to respiratory infections. However, it is unknown if COPD patients who experience frequent exacerbations have impaired humoral immunity. The aim o...

Full description

Bibliographic Details
Main Authors: Yerkovich Stephanie T, Hales Belinda J, Carroll Melanie L, Burel Julie G, Towers Michelle A, Smith Daniel J, Thomas Wayne R, Upham John W
Format: Article
Language:English
Published: BMC 2012-07-01
Series:BMC Pulmonary Medicine
Online Access:http://www.biomedcentral.com/1471-2466/12/37
_version_ 1818035949823590400
author Yerkovich Stephanie T
Hales Belinda J
Carroll Melanie L
Burel Julie G
Towers Michelle A
Smith Daniel J
Thomas Wayne R
Upham John W
author_facet Yerkovich Stephanie T
Hales Belinda J
Carroll Melanie L
Burel Julie G
Towers Michelle A
Smith Daniel J
Thomas Wayne R
Upham John W
author_sort Yerkovich Stephanie T
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are often linked to respiratory infections. However, it is unknown if COPD patients who experience frequent exacerbations have impaired humoral immunity. The aim of this study was to determine if antibodies specific for common respiratory pathogens are associated with AECOPD.</p> <p>Methods</p> <p>Plasma was obtained from COPD patients when clinically stable. AECOPD requiring hospitalisation were recorded. IgG<sub>1</sub> antibodies to <it>H. Influenzae</it> outer membrane protein 6 (P6), pneumococcal surface protein C (PspC) and the VP1 viral capsid protein of rhinovirus were measured.</p> <p>Results</p> <p>COPD patients who had an AECOPD (n = 32) had significantly lower anti-VP1 IgG<sub>1</sub> antibody levels when stable compared to COPD patients who did not have an AECOPD (n = 28, p = 0.024). Furthermore, the number of hospitalisations was inversely proportional to anti-VP1 antibody levels (r = −0.331, p = 0.011). In contrast, antibodies specific for P6 and PspC were present at similar concentrations between groups. Plasma IL-21, a cytokine important for B-cell development and antibody synthesis, was also lower in COPD patients who had an AECOPD, than in stable COPD patients (p = 0.046).</p> <p>Conclusion</p> <p>Deficient humoral immunity specific for rhinoviruses is associated with AECOPD requiring hospitalisation, and may partly explain why some COPD patients have an increased exacerbation risk following respiratory viral infections.</p>
first_indexed 2024-12-10T07:03:11Z
format Article
id doaj.art-ffdba1fd7b1449debfcefc5cd8a41a2d
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-12-10T07:03:11Z
publishDate 2012-07-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-ffdba1fd7b1449debfcefc5cd8a41a2d2022-12-22T01:58:17ZengBMCBMC Pulmonary Medicine1471-24662012-07-011213710.1186/1471-2466-12-37Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisationYerkovich Stephanie THales Belinda JCarroll Melanie LBurel Julie GTowers Michelle ASmith Daniel JThomas Wayne RUpham John W<p>Abstract</p> <p>Background</p> <p>Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are often linked to respiratory infections. However, it is unknown if COPD patients who experience frequent exacerbations have impaired humoral immunity. The aim of this study was to determine if antibodies specific for common respiratory pathogens are associated with AECOPD.</p> <p>Methods</p> <p>Plasma was obtained from COPD patients when clinically stable. AECOPD requiring hospitalisation were recorded. IgG<sub>1</sub> antibodies to <it>H. Influenzae</it> outer membrane protein 6 (P6), pneumococcal surface protein C (PspC) and the VP1 viral capsid protein of rhinovirus were measured.</p> <p>Results</p> <p>COPD patients who had an AECOPD (n = 32) had significantly lower anti-VP1 IgG<sub>1</sub> antibody levels when stable compared to COPD patients who did not have an AECOPD (n = 28, p = 0.024). Furthermore, the number of hospitalisations was inversely proportional to anti-VP1 antibody levels (r = −0.331, p = 0.011). In contrast, antibodies specific for P6 and PspC were present at similar concentrations between groups. Plasma IL-21, a cytokine important for B-cell development and antibody synthesis, was also lower in COPD patients who had an AECOPD, than in stable COPD patients (p = 0.046).</p> <p>Conclusion</p> <p>Deficient humoral immunity specific for rhinoviruses is associated with AECOPD requiring hospitalisation, and may partly explain why some COPD patients have an increased exacerbation risk following respiratory viral infections.</p>http://www.biomedcentral.com/1471-2466/12/37
spellingShingle Yerkovich Stephanie T
Hales Belinda J
Carroll Melanie L
Burel Julie G
Towers Michelle A
Smith Daniel J
Thomas Wayne R
Upham John W
Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation
BMC Pulmonary Medicine
title Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation
title_full Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation
title_fullStr Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation
title_full_unstemmed Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation
title_short Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation
title_sort reduced rhinovirus specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation
url http://www.biomedcentral.com/1471-2466/12/37
work_keys_str_mv AT yerkovichstephaniet reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation
AT halesbelindaj reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation
AT carrollmelaniel reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation
AT bureljulieg reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation
AT towersmichellea reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation
AT smithdanielj reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation
AT thomaswayner reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation
AT uphamjohnw reducedrhinovirusspecificantibodiesareassociatedwithacuteexacerbationsofchronicobstructivepulmonarydiseaserequiringhospitalisation